News

S*BIO and Onyx Pharmaceuticals Announce Expanded Development Collaboration for JAK2 Inhibitors

Singapore and Emeryville, CA, May 4, 2010 – S*BIO Pte Ltd and Onyx Pharmaceuticals, Inc.
(Nasdaq: ONXX) today announced the expansion of their development collaboration and option and
license commercialization agreement for S*BIO’s novel JAK2 inhibitors, SB1518 and SB1578, also
known as ONX 0803 and ONX 0805, respectively. The expanded agreement builds upon the
development and commercialization collaboration between the two companies announced in January
2009

Officially, Fluidigm is headquartered in South San Francisco, Calif. But from the vantage point of its facilities in the Republic of Singapore, one can see that the integrated fluidic circuit maker’s business has become a global operation.

Officially, Fluidigm is headquartered in South San Francisco, Calif. But from
the vantage point of its facilities in the Republic of Singapore, one can see that
the integrated fluidic circuit maker’s business has become a global operation.

CWT Announces EDBI as the New Investor

Singapore, 25 January 2010 – CWT Limited (“CWT” or the “Company”), a leading Singaporeheadquartered integrated logistics service provider with global operations, today announced the
subscription of 16 million new ordinary shares (the “New Shares”) by strategic investor, EDB Investments
Pte Ltd (“EDBI”).